Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Berne Stock Exchange  >  Vifor Pharma       

No quotes available
-- CHF   --.--%
05/22 VIFOR PHARMA AG : SPLIT: 10 for 1
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and markets pharmaceutical products and provides logistical & database services

Vifor Pharma AG engages in the manufacturing, development and sale of pharmaceutical products for the treatment of iron deficiency.

The company also offers a diversified portfolio of prescription medicines as well as over-the-counter products.

It operates through the following segments: Vifor Pharma, Health & Beauty, and Services.

The Vifor Pharma segment operates a fully integrated, international speciality pharmaceutical company that researches, develops and produces its own pharmaceutical products, and markets and distributes them worldwide.

The Health & Beauty segment comprises two business sectors: Products & Brands and Retail.

The Products & Brands sector is made up of Vifor Consumer Health and G-Pharma.

The G-Pharma sector is a service provider for own brands and commercial products, launches and distributes pharmaceutical and para-pharmaceutical products and offers marketing and sales services.

The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection.

The company's brands include Ferinject, Venofer and Maltofer.

Vifor Pharma was founded in 1927 and is headquartered in Bern, Switzerland.
Managers
NameAgeSinceTitle
Gianni Zampieri, PhD612002Chief Executive Officer & Director
Stefan Schulze512017President & Chief Operating Officer
Etienne Jornod641981Executive Chairman
Colin Bond, MBA562016Chief Financial Officer
Stefan Wohlfeil, MD-2012Chief Medical Officer
Daniela Bosshardt-Hengartner452008Non-Executive Director
Michel Burnier, MD642010Non-Executive Director
Fritz Hirsbrunner681977Non-Executive Director
Sylvie Louise Grégoire, PhD562013Non-Executive Director
Marc M. P. de Garidel EMBA592015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 65,000,000 46,012,840 70.8% 229,660 0.4% 70.8%
Shareholders
NameEquities%
Patinex AG 13,250,000 20.4%
Kodiak Invest AG 5,507,500 8.47%
Alecta Pension Insurance Mutual 2,100,000 3.23%
Sprint Acquisitions Holdings Ltd. 1,943,500 2.99%
Norges Bank Investment Management 1,862,330 2.87%
OppenheimerFunds, Inc. 1,669,510 2.57%
The Vanguard Group, Inc. 942,080 1.45%
Credit Suisse AG 736,172 1.13%
UBS AG (Investment Management) 731,125 1.12%
Vontobel Asset Management AG 622,530 0.96%
Holdings
NameEquities%Valuation
Galenica AG (GALE) 1,250,0002.50%58,588,700 USD
Akebia Therapeutics Inc (AKBA) 3,571,4299.20%47,857,149 USD
Vifor Pharma AG (VIFN) 231,3600.36%27,235,704 USD
ChemoCentryx Inc (CCXI) 3,333,3336.92%22,133,331 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
VIFOR PHARMA7 396
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
SANOFI14.27%123 860
BAYER22.97%112 730
GLAXOSMITHKLINE9.38%106 833
BRISTOL-MYERS SQUIBB C..-3.08%93 311
ELI LILLY AND COMPANY14.06%92 560
NOVO NORDISK A/S15.43%86 701
ASTRAZENECA21.71%86 691
ABBOTT LABORATORIES27.78%85 167
ALLERGAN PLC17.36%82 778
SHIRE-3.53%52 013
TAKEDA PHARMACEUTICAL ..19.63%40 858
TEVA PHARMACEUTICAL IN..-19.60%32 234
ASTELLAS PHARMA INC-13.78%26 111
CHUGAI PHARMACEUTICAL ..26.97%21 041
MYLAN NV2.31%20 919
Sector Pharmaceuticals - NEC
Vifor Pharma : Connections
Aktiengesellschaft Für Die Neue Zürcher Zeitung
Vifor-Fresenius Medical Care Renal Pharma Ltd.
IVF HARTMANN AG
Vifor (International) AG
European ScreeningPort GmbH
Alliance Boots GmbH
Mutuelle Vaudoise Société Coopérative
Royal Pharmaceutical Society of Great Britain
Ipsen Pharma SAS
Centre Hospitalier Universitaire Vaudois
Neue Zürcher Zeitung AG
VenCap 6 Ltd.
Alliance Boots Ltd.
Metriopharm AG
Suraypharm SAS
Corvidia Corp.
PX Therapeutics SA
Shire Orphan Therapies GmbH
ESSEC Business School
Verve Capital Partners AG
European Federation of Pharmaceutical Industries & Assns
European Research Council
Société Des Membres De La Légion D'Honneur
European Society of Hypertension
The Innovative Medicines Initiative
Speedel Pharma AG
ESCP Europe Campus Paris
Company contact information
Vifor Pharma AG
Untermattweg 8
Bern, Bern (Berne) 3027

Phone : +41.58.852.81.11
Fax : +41.58.852.81.12
Web : www.viforpharma.com
© 2017 People , Fundamentals and Ownership